A bunch of bears. Don't enter if you don't have a position, don't sell if you have shares
$Pfizer(PFE.US$ Let the agency fight and make a clear fight before making a decision. Too many anti-vaccinators are affecting sales. The mRNA patent lawsuit with Moderna will take half a year, to say the least. Last week GSK also joined the war (London has the advantage of a base camp). Actually, Moderna shouldn't have traveled to this muddy water. UPenn's core patents have been oversold, making a mess of accounts. Moderna is neither an inventor nor a rights holder; the patent applied for is precautionary and very problematic.
It's like applying for a patent to build a house on the moon, and they'll get it. I really want to build a house... Civil Law System: Uh, if you want to prove that Jordan Sports is a flyer, Jordan needs proof. Common law jury: Don't insult our intelligence; you haven't built a house on the moon; you're just stealing traffic. If you find a way to get a patent Lian Meng, you just have to master derivative IP well. Established companies have quite a few full time litigators, which are not easy to do
The picture is still sorted out. Let's talk about it when it's ready (cross the 200-day EMA). At that point, it was only 30 yuan, making 10% less, but much safer. The big hidden danger now is that the bottom was broken for a while, and institutions are not buying enough.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment